No Result
View All Result
China Secrets Revealed
  • Economy
  • Editor’s Pick
  • Investing
  • News
  • Stock
  • Economy
  • Editor’s Pick
  • Investing
  • News
  • Stock
No Result
View All Result
China Secrets Revealed
No Result
View All Result
Home Stock

Shellfish, Typhoid, and Private Control of Disease

by
April 8, 2026
in Stock
0
Shellfish, Typhoid, and Private Control of Disease

Jeffrey Miron

According to a recent study, early 20th-century London fishmongers provided a creative solution for the problem of foodborne typhoid transmission. 

The issue was that shellfish

acted as vectors for waterborne diseases … Once the connection was understood, consumers alone could have substantially reduced typhoid deaths by consuming far fewer shellfish. 

Instead, a prominent fishmonger company 

used the Billingsgate [fish] market to help high-quality sellers signal the quality of their products by sampling and testing harvest sites, banning sales from known contaminated areas, and requiring vendors to purchase shellfish cleaning services. 

This strategy meant that 

consumers who were willing to risk their own quality control could purchase shellfish for a lower price from traders who did not transit through Billingsgate, while those willing to pay a premium for third-party quality control purchased shellfish through Billingsgate. 

Profit-motivated companies can create public goods.

Cross-posted from Substack.

Previous Post

Applied Digital earnings preview: Is APLD stock a buy now?

Next Post

Nvidia stock is up around 2%: can it finally breakthrough?

Next Post
Nvidia stock is up around 2%: can it finally breakthrough?

Nvidia stock is up around 2%: can it finally breakthrough?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest
Why JPMorgan sees further upside in Palo Alto and CrowdStrike stocks

Why JPMorgan sees further upside in Palo Alto and CrowdStrike stocks

0
TD Cowen downgrades Molson Coors, lowers price target to $58: Is it time to exit?

TD Cowen downgrades Molson Coors, lowers price target to $58: Is it time to exit?

0
Google’s antitrust ruling draws parallels to Microsoft’s 25-year-old case: Here’s how

Google’s antitrust ruling draws parallels to Microsoft’s 25-year-old case: Here’s how

0
In 2023, Colorado Lawmakers Pushed Back on Cops Practicing Pain Medicine Based on Flawed CDC Guideline

In 2023, Colorado Lawmakers Pushed Back on Cops Practicing Pain Medicine Based on Flawed CDC Guideline

0
Why JPMorgan sees further upside in Palo Alto and CrowdStrike stocks

Why JPMorgan sees further upside in Palo Alto and CrowdStrike stocks

April 8, 2026
Nvidia stock is up around 2%: can it finally breakthrough?

Nvidia stock is up around 2%: can it finally breakthrough?

April 8, 2026
Shellfish, Typhoid, and Private Control of Disease

Shellfish, Typhoid, and Private Control of Disease

April 8, 2026
Applied Digital earnings preview: Is APLD stock a buy now?

Applied Digital earnings preview: Is APLD stock a buy now?

April 8, 2026

Recent News

Why JPMorgan sees further upside in Palo Alto and CrowdStrike stocks

Why JPMorgan sees further upside in Palo Alto and CrowdStrike stocks

April 8, 2026
Nvidia stock is up around 2%: can it finally breakthrough?

Nvidia stock is up around 2%: can it finally breakthrough?

April 8, 2026
Shellfish, Typhoid, and Private Control of Disease

Shellfish, Typhoid, and Private Control of Disease

April 8, 2026
Applied Digital earnings preview: Is APLD stock a buy now?

Applied Digital earnings preview: Is APLD stock a buy now?

April 8, 2026

Disclaimer: ChinaSecretsRevealed.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 ChinaSecretsRevealed. All Rights Reserved.

No Result
View All Result
  • Economy
  • Editor’s Pick
  • Investing
  • News
  • Stock

Copyright © 2024 ChinaSecretsRevealed. All Rights Reserved.